Journal of Pharmacological Sciences · 2019 · 26 citations · 27 references
MedicineCell BiologyPharmacologyCell SignalingMolecular PharmacologySignal TransductionAnalgesiaAnalgesic PharmacologyG Protein-coupled Receptor SignalingOpioid AnalgesicsOpioid PharmacologyReceptor PharmacologyAgonist ActivityAnalgesic EffectsBeta-arrestin-mediated SignalingFull Agonist EfficacyOpioid Receptor AgonistsReceptor-mediated AnalgesiaReceptorsβ-Arrestin-mediated Internalization
values measured by cAMP and CellKey™ assays had potencies in the order fentanyl ≤ hydromorphone < morphine ≤ oxycodone, all also exhibiting full agonist responses. However, in the internalization assay, only fentanyl elicited a full agonist response. Hydromorphone had the strongest potency next to fentanyl; however, contribution of the β-arrestin-mediated pathway was small, suggesting that its effect could be biased toward the G protein-mediated pathway. Based on these properties, hydromorphone could be chosen as an effective analgesic.
27
Opioid Complications and Side Effects
Ramsin Benyamin · Pain Physician · 2008 · 2.2K citations
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Laura Bohn, Robert J. Lefkowitz, Raul R. Gainetdinov et al. · Science · 1999 · 1.1K citations
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Marie Fallon, Raffaele Giusti, Federica Aielli et al. · Annals of Oncology · 2018 · 893 citations · Full text
Morphine and alternative opioids in cancer pain: the EAPC recommendations
G.W. Hanks, Franco De Conno, Nathan I. Cherny et al. · British Journal of Cancer · 2001 · 852 citations · Full text
Nursing, Oncology, Pharmacotherapy +17
Scott M. DeWire, Dennis S. Yamashita, David H. Rominger et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 655 citations